Insulin Receptor Substrate 1 (IRS1) Gene Variation Modifies Insulin Resistance Response to Weight-loss Diets in A Two-year Randomized Trial
|
|
- Cameron Powers
- 5 years ago
- Views:
Transcription
1 Nutrition, Physical Activity and Metabolism Conference 2011 Insulin Receptor Substrate 1 (IRS1) Gene Variation Modifies Insulin Resistance Response to Weight-loss Diets in A Two-year Randomized Trial Qibin Qi, Frank M. Sacks, Frank B. Hu, Lu Qi Department of Nutrition Harvard School of Public Health March 23, 2011
2 Presenter Disclosure Information Financial Disclosure: No relevant financial relationship exists Funding/Support: This study was supported by grants from the National Heart, Lung, and Blood Institute (HL071981), the General Clinical Research Center (RR-02635) and the Boston Obesity Nutrition Research Center (DK46200). Dr. Lu Qi was a recipient of the American Heart Association Scientist Development Award ( N)
3 Gene-Environment Interactions Dietary Intervention Reduced-calorie diets Weight Loss Insulin resistance Improvement Genetic Background
4 Insulin Receptor Substrate 1 (IRS1) Muscle Liver Insulin receptor substrate 1 (IRS1) in insulin signaling Adapt from Samuel et al.the Lancet. 2010;375: Rung et al. Nat Genet. 2009;41(10): A 4-week intervention study reported that IRS1 gene variation (G972R) might modulate the effect of a low-fat and high-carbohydrate diet on insulin sensitivity (n=59) Marín et al. Molecular Nutrition & Food Research :
5 Objective To examine whether the IRS1 genetic variant rs (the best-associated SNP) modifies the long-term changes in insulin resistance and body weight in response to four weight-loss diets in a two-year randomized trial (the Pounds Lost Trial)
6 The Pounds Lost Trial A 2-year randomized clinical trial 811 overweight adults Four diets varying in macronutrients To compare the effects of macronutrients Four Reduced-calorie Diets Resulted in Similar Weight Loss on weight-loss Trial Registration No.: NCT Nutrient goals for the 4 diet groups (percentages of energy) Diet Group Fat (%) Protein (%) Carbohydrate (%) The diets consisted of similar foods and met guidelines for cardiovascular health, and carbohydrate-rich foods were used having a lower glycemic index Sacks et al, NEJM, 360 (9): , 2009
7 Methods Participants 738 subjects with DNA sample available were included 91% of the entire Pounds Lost trial 61% were women 80% were white, 15% were African American, 5% were other ethnic groups Genotyping IRS1 SNP rs Endpoints Changes in body weight, fasting insulin and insulin resistance (estimated by HOMA-IR) at 6 months and 2 years Statistical analysis Generalized linear models: Genotype-intervention interactions at 6 months and 2 years Genotype effects in each of 4 diet groups at 6 months and 2 years Linear mixed models Genotype effect on the trajectory of changes in each of 4 diet groups over the 2-year intervention
8 Characteristics of Participants Results Table 1. Baseline characteristics according to the IRS1 rs genotype IRS1 rs CC (risk) CT TT N (%) 331 (44.9) 312 (42.3) 95 (12.8) P* Age, yr 51 ± 9 51 ± 9 50 ± Sex, n (%) 0.19 Female 213 (64.4) 179 (57.4) 59 (62.1) Male 118 (35.6) 133 (42.6) 36 (37.9) Diet groups (fat/ protein/ carbohydrate), n (%) 0.63 Group 1 (20/15/65%) 83 (44.4) 82 (43.8) 22 (11.8) Group 2 (20/25/55%) 91 (50.0) 69 (37.9) 22 (12.1) Group 3 (40/15/45%) 74 (39.8) 86 (46.2) 26 (14.0) Group 4 (40/25/35%) 83 (45.4) 75 (41.0) 25 (13.7) Weight, kg 94 ± ± ± BMI, kg/m 2 33 ± 4 32 ± 4 33 ± Insulin, µu/ml 10.8 ( ) 10.4 ( ) 9.3 ( ) HOMA-IR 2.4 ( ) 2.3 ( ) 2.0 ( ) * P-values were calculated by χ 2 test for categorical variables, and F test for continuous variables
9 Genotype Effect on weight Loss at 6 months Results Highest-carbohydrate diet Lowest-carbohydrate diet 0 Diet 1 (20/15/65%) Diet 2 (20/25/55%) Diet 3 (40/15/45%) Diet 4 (40/25/35%) Weight Loss (%) IRS1 rs P=0.01 P=0.22 P=0.33 P=0.22 P for interaction =0.03 CC CT+TT
10 Improvement in Insulin Resistance at 6 months Results 0 Diet 1 (20/15/65%) Diet 2 (20/25/55%) Diet 3 (40/15/45%) Diet 4 (40/25/35%) Change in Log-insulin P=0.009 P=0.15 P=0.56 P=0.05 P for interaction =0.01 IRS1 rs CC CT+TT 0 Change in Log-HOMA-IR P=0.01 P=0.18 P=0.56 P=0.05 P for interaction =0.01
11 Genotype Effect on Weight Loss at 2 Years Results 0 Diet 1 (20/15/65%) Diet 2 (20/25/55%) Diet 3 (40/15/45%) Diet 4 (40/25/35%) Weight Loss (%) IRS1 rs P=0.32 P=0.71 P=0.81 P=0.17 P for interaction =0.23 CC CT+TT
12 Improvement in Insulin Resistance at 2 Years Results 0 Diet 1 (20/15/65%) Diet 2 (20/25/55%) Diet 3 (40/15/45%) Diet 4 (40/25/35%) Change in Log-insulin P=0.02 P=0.79 P=0.86 P=0.11 P for interaction =0.07 IRS1 rs CC CT+TT Change in Log-HOMA-IR P=0.02 P=0.83 P=0.97 P=0.09 P for interaction =0.07
13 The Trajectory of Changes over Intervention Results Genotype*time interaction in the highest-carbohydrate diet group
14 Significance and Limitation Assessed the gene-diet interactions on improvement of insulin resistance with weight-loss in a large and long-term randomized trial Provide novel information to the development of effective strategies for dietary interventions based on genetic background Insulin resistance was assessed by HOMA-IR rather than by using euglycemic glucose clamp technique Adherence to various diets declined after 6 months Most of the participants are whites (80%) Potential mechanisms are unclear
15 Summary Subjects with the CC genotype had greater weight loss and improvement in insulin resistance in the highest carbohydrate diet group at 6 months Genotype effect on changes in insulin resistance remained significant in subjects assigned to the highest carbohydrate diet group at 2 years Individuals with the IRS1 rs CC genotype might obtain more benefits in weight loss and improvement of insulin resistance than those without this genotype by choosing a high-carbohydrate and low-fat diet
16 Acknowledgements Harvard School of Public Health: Drs Frank M. Sacks, Frank B. Hu, Lu Qi and colleagues in our group Pennington Biomedical Research Center of the Louisiana State University System: Drs George A. Bray and Steven R. Smith We thank the participants in the trial for their dedication and contribution to the research! Thank You for Your Attention!
Cardiology Department and Center for Research and Prevention of Atherosclerosis, Hadassah Hebrew University Medical Center.
CETP and IRS1 Genetic Variation Modulates Effects of Weight loss Diets on Lipid Profile in Two Independent 2 Year Diet Intervention Studies: The Pounds Lost and DIRECT Trails Ronen Durst, MD Cardiology
Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012
Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE 40 yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: Robert B. Baron MD MS Professor and
Improving cardiometabolic health in Major Mental Illness
Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic
Introduction To The Zone
Introduction To The Zone Why Do We Gain Weight, Get Sick, and Age Faster? Overview of Anti- Inflammatory Nutrition Unique Roles For Each Dietary Intervention Zone Diet Reduction of insulin resistance Omega-3
Body Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
Dietary Composition for Weight Loss and Weight Loss Maintenance
Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation
The South Asian Indian Women s s Weight Loss Study. Latha Palaniappan, MD, MS BIRCWH Scholar October 20, 2005
The South Asian Indian Women s s Weight Loss Study Latha Palaniappan, MD, MS BIRCWH Scholar October 20, 2005 South Asian Emigrants and second generation from India Bhutan Bangladesh Maldives Nepal Pakistan
Effects of macronutrients on insulin resistance and insulin requirements
Effects of macronutrients on insulin resistance and insulin requirements Dr Duane Mellor RD Assistant Professor in Dietetics, The University of Nottingham, UK Outline of Discussion Issues of determining
Family History and Diabetes. Practical Genomics for the Public Health Professional
Family History and Diabetes Practical Genomics for the Public Health Professional Outline Overview of Type 2 Diabetes/Gestational Diabetes Familial/Genetic Nature of Diabetes Interaction of Genes and Environment
A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011
A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011 Jeff S. Volek, Ph.D., R.D. Human Performance Laboratory Department of Kinesiology University of Connecticut Storrs,
ALPHA (TNFa) IN OBESITY
THE ROLE OF TUMOUR NECROSIS FACTOR ALPHA (TNFa) IN OBESITY Alison Mary Morris, B.Sc (Hons) A thesis submitted to Adelaide University for the degree of Doctor of Philosophy Department of Physiology Adelaide
Causes, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Solomon S. Steiner, Lutz Heinemann, Roderike Pohl, Frank Flacke, Andreas Pfützner, Patrick V. Simms, Marcus Hompesch. EASD September 18, 2007
Pharmacokinetics and Pharmacodynamics of Insulin VIAject TM, Insulin Lispro and Regular Human Insulin When Injected Subcutaneously Immediately Before a Meal in Patients with Type 1 Diabetes. Solomon S.
Dieting and Gallstones
Dieting and Gallstones WIN Weight-control Information Network What are Gallstones are clusters of solid material that form in the gallbladder. The most common type is made mostly of cholesterol. Gallstones
Traditional View of Diabetes. Are children with type 1 diabetes obese: What can we do? 8/9/2012. Change in Traditional View of Diabetes
Are children with type 1 diabetes obese: What can we do? Traditional View of Diabetes Type 1 Diabetes ( T1DM) Onset Juvenile Lean Type 2 Diabetes ( T2DM) Onset Adult Obese QI Project Indrajit Majumdar
Insulin s Effects on Testosterone, Growth Hormone and IGF I Following Resistance Training
Insulin s Effects on Testosterone, Growth Hormone and IGF I Following Resistance Training By: Jason Dudley Summary Nutrition supplements with a combination of carbohydrate and protein (with a ratio of
Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c
Calculating and Graphing Glucose, Insulin, and GFR HASPI Medical Biology Activity 19c Name: Period: Date: Part A Background The Pancreas and Insulin The following background information has been provided
ESPEN Congress Brussels 2005
ESPEN Congress Brussels 2005 Low carbohydrate or low fat diet to loose weight: Pro Low Fat Diets Arne Astrup 27th ESPEN Congress 28 August 2005 Low carbohydrate or low fat diet to loose weight: Pro Low
7 Ways Your DNA Influences Your Ability to Lose Weight
7 Ways Your DNA Influences Your Ability to Lose Weight Weight loss is a multi-billion dollar industry affecting millions of people each year. And it s no surprise that most of the collective thought about
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,
Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
PLEASE NOTE: This trial has been registered retrospectively. Trial Description Title Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
Is Insulin Effecting Your Weight Loss and Your Health?
Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults
Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE
Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Assistant
Give a NOD to diabetes:
Give a NOD to diabetes: NOD proteins ti link immunity it and metabolism tbli Jonathan Schertzer McMaster University McMaster University Faculty of Health Sciences Department of Biochemistry and Biomedical
Introduction. Pathogenesis of type 2 diabetes
Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic
Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
Menopause. Weight Loss. A Special Report on Weight Gain During Menopause. contact us. FROM THE DESK OF: Carolyn J. Cederquist, M.D. Dr.
Weight Loss & A Special Report on Weight Gain During Menopause Menopause FROM THE DESK OF: Carolyn J. Cederquist, M.D. Dr. Cederquist Caroline J. Cederquist, M.D., has appeared as a weight-management expert
Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
Alzheimer s disease and diabetes
1007029 CM1053CS Alzheimer s disease and diabetes Nearly 21 million Americans in the United States have diabetes, a disease that makes the body less able to convert sugar to energy. More than 6 million
The Skinny on Visceral Fat
The Skinny on Visceral Fat Fat stored deep in the belly is the most harmful kind. Find out how to cut it down to size. People can carry their extra weight in different places on the body: All over On the
journal of medicine The new england Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates Abstract
The new england journal of medicine established in 1812 february 26, 29 vol. 36 no. 9 Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates Frank M. Sacks, M.D.,
Grand V Challenge We must improve human health, nutrition and wellness of the U.S. population
Grand V Challenge We must improve human health, nutrition and wellness of the U.S. population 1 Current Health Challenges Large health care costs(estimates range from $2.5 to $3 trillion in 2008 and 2009)
Endocrine System: Practice Questions #1
Endocrine System: Practice Questions #1 1. Removing part of gland D would most likely result in A. a decrease in the secretions of other glands B. a decrease in the blood calcium level C. an increase in
DIABETES AND INSULIN RESISTANCE DIABETES PREVALANCE
DIABETES AND INSULIN RESISTANCE KARI KOHRS RD LDN CDE UICMC NUTRITION & WELLNESS CENTER DIABETES PREVALANCE Third leading cause of death-- United States 18 million diagnosed Growing at the rate of 3 new
Disruptive Dairy innovation: Why has it become a necessity for the food industry?
Disruptive Dairy innovation: Why has it become a necessity for the food industry? Jens Bleiel CEO FHI June 16, 2015 Alicante 4topics 1 Dairy innovation : Why is it so difficult? 2 Formula 1 and the Man
The Glycemic Index. Professor, Pediatrics, Harvard Medical School Professor, Nutrition, Harvard School of Public Health
The Glycemic Index David S. Ludwig, MD, PhD Director, Optimal Weight for Life (OWL) Program Director, New Balance Foundation Obesity Prevention Center Children s Hospital Boston Professor, Pediatrics,
Jill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
C-Reactive Protein and Diabetes: proving a negative, for a change?
C-Reactive Protein and Diabetes: proving a negative, for a change? Eric Brunner PhD FFPH Reader in Epidemiology and Public Health MRC Centre for Causal Analyses in Translational Epidemiology 2 March 2009
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment. Bruce Latham, M.D. Endocrine Specialists Greenville Health System
Type 2 Diabetes and Prediabetes: A New Understanding of Cause and Treatment Bruce Latham, M.D. Endocrine Specialists Greenville Health System Objectives for this presentation - Understand the thrifty genotype
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE
NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
Humulin (LY041001) Page 1 of 1
(LY041001) These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDA-approved package insert or
Do You Know the Health Risks of Being Overweight?
Do You Know the Health Risks of Being Overweight? U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH WIN Weight-control Information Network What are the risks to my health from
Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD
Normal and Abnormal Aging and the Brain Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD The myth of cognitive decline The myth of cognitive decline Individual change varies Individual change varies
PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison
PATHWAYS TO TYPE 2 DIABETES Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison Overview Diabetes 101 How does diabetes work Types of diabetes Diabetes in numbers
The Need for an Integrative Approach to Pediatric Obesity
The Need for an Integrative Approach to Pediatric Obesity David S. Ludwig, MD, PhD Associate Director, Clinical & Translational Studies Unit Director, Optimal Weight for Life (OWL) Program Children s Hospital
Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance
Reversing type 2 diabetes: pancreas composition and function during return to normal glucose tolerance Dr Sarah Steven Clinical Research Fellow to Professor Roy Taylor Observations from bariatric surgery
Calories. 23 calories from fat + 48 calories from carbohydrates + 32 calories from protein = 103 Calories in 1 cup of 1% milk
Calories What's the magical formula to achieve your weight goals? Calorie needs are based on individual needs. In order for your weight to stay the same, the energy (or Calories) you consume must equal
Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005
Cardiovascular Disease Risk Factors Part XII By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005 As we approach the end of our extended series on cardiovascular disease risk factors,
Insulin Resistance and Prediabetes
Insulin Resistance and Prediabetes National Diabetes Information Clearinghouse What is insulin? Insulin is a hormone made in the pancreas, an organ located behind the stomach. The pancreas contains clusters
CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
Appendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
Eat like a pig for better health?
Eat like a pig for better health? Theo van Kempen Senior Researcher, Nutreco Adjunct professor in Nutrition, North Carolina State University Ph.D., Human Nutrition, University of Illinois Pigging out,
Diabetes and Obesity. The diabesity epidemic
Diabetes and Obesity Frank B. Diamond, Jr. M.D. Professor of Pediatrics University of South Florida College of Medicine The diabesity epidemic Prevalence of diabetes worldwide was over 135 million people
Using Family History to Improve Your Health Web Quest Abstract
Web Quest Abstract Students explore the Using Family History to Improve Your Health module on the Genetic Science Learning Center website to complete a web quest. Learning Objectives Chronic diseases such
Sedentarity and Exercise in the Canadian Population. Angelo Tremblay Division of kinesiology
Sedentarity and Exercise in the Canadian Population Angelo Tremblay Division of kinesiology Disclosure of Potential Conflicts of Interest Évolution de la pratique d activité physique des adultes canadiens
GloP1r - A New Frontier in Exercise and Nutrition
Central Florida Research Update Ayala, Julio, PhD, Sanford-Burnham Medical Research Institute, Orlando, Florida Anorectic Mechanisms of Glp1r Agonists Obesity Jan 1, 2014 Dec 31, 2018 Integrated Physiology,
Kansas Behavioral Health Risk Bulletin
Kansas Behavioral Health Risk Bulletin Kansas Department of Health and Environment November 7, 1995 Bureau of Chronic Disease and Health Promotion Vol. 1 No. 12 Diabetes Mellitus in Kansas Diabetes mellitus
The Key to Natural Weight Management Support. Presented by Sabinsa Corporation
The Key to Natural Weight Management Support Presented by Sabinsa Corporation LeanGard A bioavailable combination of natural ingredients that addresses multiple targets in weight management: Supports Lean
diet-related chronic diseases
5. Population nutrient intake goals for preventing diet-related chronic diseases 5.1 Overall goals 5.1.1 Background Population nutrient intake goals represent the population average intake that is judged
Epigenetic variation and complex disease risk
Epigenetic variation and complex disease risk Caroline Relton Institute of Human Genetics Newcastle University ALSPAC Research Symposium 2 & 3 March 2009 Missing heritability Even when dozens of genes
With DNA test learn, what exercise level & foods are best for you
With DNA test learn, what exercise level & foods are best for you Antelias, Highway, Antoine El Kassis Bldg. /, Can your genes affect the way you maintain weight? ForeverSlim has the first comprehensive
How To Get A Better Health Care Package For A Black Person
Incidence of Type 2 Diabetes in Hispanics as Compared to the General Population in Massachusetts By Isabelle Pierre Krystal Amaral, and Ardrianna Howard, 2014 SEP Participants 1 TYPE 2 DIABETES MELLITUS
Diet And Insulin Resistance Syndrome
Focus on CME at the University of Toronto Dietary Carbohydrates In The Insulin Resistance Syndrome The areas of carbohydrates, glycemic index of foods and physical activity all play very important roles
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN
BEST & WORST FOODS FOR BELLY FAT
Belly fat is worse for you than fat elsewhere on your body. Excess accumulation of belly fat is more dangerous than excess fat around your hips and thighs. Belly fat is associated with serious health problems,
嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
Triglycerides: Frequently Asked Questions
Triglycerides: Frequently Asked Questions Why are triglycerides important? The amount of triglycerides (or blood fats) in blood are one important barometer of metabolic health; high levels are associated
Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc.
Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc. UIC study finds subjects on Isagenix products lost more body fat, lost more visceral fat, showed greater adherence,
High Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
Role of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
Low diabetes numeracy predicts worse glycemic control
Low diabetes numeracy predicts worse glycemic control Kerri L. Cavanaugh, MD MHS, Kenneth A. Wallston, PhD, Tebeb Gebretsadik, MPH, Ayumi Shintani, PhD, MPH, Darren DeWalt, MD MPH, Michael Pignone, MD
Supplemental Data. Article. Insulin Action in AgRP-Expressing Neurons. Is Required for Suppression. of Hepatic Glucose Production
Cell Metabolism, Volume 5 Supplemental Data Article Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production A. Christine Könner, Ruth Janoschek, Leona Plum,
Diabetes and Weight-Loss Surgery
WHITE PAPER Diabetes and Weight-Loss Surgery Treat the cause. Cure the symptom. Center of Excellence BARIATRIC SURGERY Written July 2011 Bariatric Surgery: The Cure for Type II Diabetes? For most individuals
Adult Weight Management Training Summary
Adult Weight Management Training Summary The Commission on Dietetic Registration, the credentialing agency for the Academy of Nutrition and Dietetics Marilyn Holmes, MS, RDN, LDN About This Presentation
Baskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
Resumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
The Influence of Infant Health on Adult Chronic Disease
The Influence of Infant Health on Adult Chronic Disease Womb to Tomb Dr Clare MacVicar Introduction Many diseases in adulthood are related to growth patterns during early life Maternal nutrition important
Life Style and Nutritional Profile of Non-Insulin Dependent Diabetes Mellitus (NIDDM) Patients
Life Style and Nutritional Profile of Non-Insulin Dependent Diabetes Mellitus (NIDDM) Patients Kaur, I. P. and Kalra, R. Govt. College for Girls, Patiala-147001, Punjab, India Abstract The present investigation
Behavioral Lifestyle Intervention in the Treatment of Obesity
Health Services Insights Review Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Behavioral Lifestyle Intervention in the Treatment of Obesity Shannon M. Looney
Minnesota Studies of Health Education and Environmental Approaches to Obesity Treatment and Prevention
Minnesota Studies of Health Education and Environmental Approaches to Obesity Treatment and Prevention Robert W. Jeffery, Ph.D. University of Minnesota USA Prevalence of Obesity (BMI 30) in US Adults,
If you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
Section C. Diet, Food Production, and Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
The Diabetes Prevention Program's Lifestyle Change Program
The Diabetes Prevention Program's Lifestyle Change Program Section 5: Overview of Strategies to Achieve the Weight Loss Goal Copyright 1996 by the University of Pittsburgh. Developed by the Diabetes Prevention
The Marvelous Mitochondria Understanding the Cell s Energy Power Plant Len Kravitz, Ph.D.
The Marvelous Mitochondria Understanding the Cell s Energy Power Plant Len Kravitz, Ph.D. The mitochondrion (or mitochondria in its plural form) is a specialized organelle found in most eukaryotic cells
Master of Science. Obesity and Weight Management
Department of Clinical Sciences and Nutrition Master of Science in Obesity and Weight Management Dublin Part-Time Taught Modular Masters Programme Module Descriptor Outlines XN7201 The Obesity Epidemic
Development and testing of a mobile phone application for weight loss
Development and testing of a mobile phone application for weight loss Victoria J Burley Michelle Carter Janet E Cade Funding from: National Prevention Research Initiative (NPRI) grant number G0802108 Background
Statistics of Type 2 Diabetes
Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often
LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti. Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova
LA TERAPIA PER HBV ed HCV Differenze di Genere? Alfredo Alberti Dipartimento di Medicina Molecolare UOC Medicina Generale VIMM Università di Padova HBV ed HCV Due virus Diversi ma con molte Cose in Comune
NUTRITION MACRONUTRIENT RATIO
It s that time of year again when we say goodbye to summertime shorts, slops and vests and say hello to long pants, coats and thermal underwear. While most people despise the chilly winter, for those of
GLYCINE SUPPLEMENTATION TO IMPROVE INSULIN SENSITIVITY IN HUMANS BONI EPSE ATTOBLA MARIE HIPPOLYTE SUSAN MILLER, COMMITTEE CHAIR W.
GLYCINE SUPPLEMENTATION TO IMPROVE INSULIN SENSITIVITY IN HUMANS by BONI EPSE ATTOBLA MARIE HIPPOLYTE SUSAN MILLER, COMMITTEE CHAIR W. TIMOTHY GARVEY JOSE FERNANDEZ ELIZABETH KITCHIN A THESIS Submitted
Nonalcoholic Fatty Liver Disease. Dietary and Lifestyle Guidelines
Nonalcoholic Fatty Liver Disease Dietary and Lifestyle Guidelines Risk factors for NAFLD Typically, but not always seen in patients who are overweight. May have Diabetes and or insulin resistance high
Welcome to Diabetes Education! Why Should I Take Control of My Diabetes?
Welcome to Diabetes Education! Why Should I Take Control of My Diabetes? NEEDS and BENEFITS of SELF-MANAGEMENT You make choices about your life and health Controlling diabetes needs every day decisions
Surgical Weight Loss Program for Teens
Surgical Weight Loss Program for Teens Surgical Weight Loss Program for Teens The Surgical Weight Loss Program team understands the impact that being severely overweight can have on your life. Our guiding
Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus?
Why is HDL Cholesterol Low in People with Insulin Resistance and Type 2 Diabetes Mellitus? Henry Ginsberg, MD Columbia University College of Physicians and Surgeons Henry Ginsberg: Disclosures Research